Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Human Genome Sciences
AddedFeb 17, 2024
UpdatedJun 28, 2026
Human Genome Sciences

Human Genome Sciences

Acquired

Former US pharma firm, Human Genome Sciences, now part of GlaxoSmithKline, pioneers gene-based disease solutions.

HQ
Rockville, MD, US
Founded
1992
Overview
Compare
Employees
Website

Human Genome Sciences, Inc., founded in the United States, was a pioneering pharmaceutical company dedicated to researching and developing proprietary pharmaceutical and diagnostic products. The company's core mission was to leverage the discovery of human and microbial genes to predict, prevent, detect, treat, and cure diseases. Their market focus included gene-based solutions for various health conditions, utilizing advanced technologies like AI and machine learning to enhance their research capabilities.

Notable figures associated with Human Genome Sciences included its founders and key researchers who contributed significantly to the field of genomics. The company attracted substantial investment from leading biotech investors before being acquired by GlaxoSmithKline. Key achievements included the development of innovative gene-based therapies and diagnostics that have had a lasting impact on personalized medicine. Overall, Human Genome Sciences played a crucial role in advancing genomic research and its application in modern medicine.

Human Genome Sciences - Similar Companies

GSK logo

GSK

gsk.com

Gilead Sciences logo

Gilead Sciences

gilead.com

GeneDx Holdings logo

GeneDx Holdings

genedx.com

Gene Sciences logo

Gene Sciences

Myriad Genetics logo

Myriad Genetics

myriad.com

Genentech logo

Genentech

gene.com

Gene Solutions logo

Gene Solutions

Geneicd logo

Geneicd

Genomenon logo

Genomenon

genomenon.com

Foundation Medicine logo

Foundation Medicine

Kyntra Bio logo

Kyntra Bio

fibrogen.com

MacroGenics logo

MacroGenics

macrogenics.com

Genome Medical logo

Genome Medical

genomemedical.com

Bristol Myers Squibb logo

Bristol Myers Squibb

bms.com

Sangamo Therapeutics logo

Sangamo Therapeutics

sangamo.com

Human Genome Sciences - Quick Facts

Who are Human Genome Sciences' competitors?

Companies similar to Human Genome Sciences include GSK, Gilead Sciences, GeneDx Holdings and Gene Sciences.

When was Human Genome Sciences founded?

Human Genome Sciences was founded in 1992.

Where is Human Genome Sciences' headquarters located?

Human Genome Sciences' headquarters is located in Rockville, MD, US.

Human Genome Sciences - Classification

Ownership
  • Public
Technology
  • AI
  • Machine Learning
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Diagnostics
  • Pharmaceuticals
Tags
  • Biotech
  • Healthcare
  • Healthtech
  • Research
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 23 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325414Biological Product (except Diagnostic) Manufacturing
  • 541110Offices of Lawyers
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 541100Legal Services
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2835In Vitro And In Vivo Diagnostic Substances
  • 2836Biological Products, Except Diagnostic Substances
  • 8100Legal Services
  • 8110Legal Services
  • 8111Legal Services
  • 2800Chemicals And Allied Products
  • 4000Railroad Transportation
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
ISIC
  • 6910Legal activities